Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey

Thornsberry, 2000, Resistance in respiratory tract pathogens: an international study 1997–1998, J. Chem., 12, 16 Cornaglia, 2000, Epidemiological survey of bacterial resistance in upper respiratory tract infections in Italy, Int. J. Antimicrob. Agents, 16, 259, 10.1016/S0924-8579(00)00255-7 Doern, 1997, Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study, Antimicrob. Agents Chemother., 41, 292, 10.1128/AAC.41.2.292 Baquero, 1998, Epidemiology and mechanisms of resistance among respiratory tract pathogens, Clin. Microbiol. Infect., 4, 19 Hoban, 2001, Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997–1999, Clin. Infect. Dis., 32, S81, 10.1086/320181 Thornsberry, 1997, Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season, Diagn. Microbiol. Infect. Dis., 29, 249, 10.1016/S0732-8893(97)00195-8 Livermore, 1995, β-lactamases in laboratory and clinical resistance, Clin. Microbiol. Rev., 8, 557, 10.1128/CMR.8.4.557-584.1995 Cornaglia G, Ligozzi M, Mazzariol A, Masala L, Lo Cascio G, Orefici G. The Italian Surveillance Group for Antimicrobial Resistance, and Fontana R. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin Infect Dis 1998;27(Suppl. 1):S87–92. Bandak, 2000, Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries, Int. J. Clin. Pract., 54, 585 National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement. Approved standard, document M100-S9. National committee for Clinical Laboratory Standards: Wayne, PA, 1999. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests-sixth edition. Approved standard, document M2-A6. National committee for Clinical Laboratory Standards: Wayne, PA, 1999. Pontani, 1998, Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin, Eur. J. Clin. Microbiol. Infect. Dis., 17, 413, 10.1007/BF01691574 Goldstein, 1995, Epidemiology of antibiotic resistance in Haemophilus influenzae, Microb. Drug Resist., 1, 131, 10.1089/mdr.1995.1.131 Mendelman, 1984, Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae, Antimicrob. Agents Chemother., 26, 235, 10.1128/AAC.26.2.235 Bandak, 2001, Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteeen countries, Eur. J. Clin. Microbiol. Infect. Dis., 20, 55, 10.1007/s100960000427 Schito, 2000, The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project, J. Antimicrob. Chemother., 46, 3, 10.1093/oxfordjournals.jac.a020891 Fung, 1992, The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991, J. Antimicrob. Chemother., 30, 47, 10.1093/jac/30.1.47